These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29227894)

  • 21. Axis I comorbidity of borderline personality disorder.
    Zanarini MC; Frankenburg FR; Dubo ED; Sickel AE; Trikha A; Levin A; Reynolds V
    Am J Psychiatry; 1998 Dec; 155(12):1733-9. PubMed ID: 9842784
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impulsive clinical profile of Borderline Personality Disorder with comorbid Substance Use Disorder.
    Calvo N; Valero S; Ferrer M; Barral C; Casas M
    Actas Esp Psiquiatr; 2016 Jul; 44(4):145-52. PubMed ID: 27388106
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Distinguishing bipolar II depression from major depressive disorder with comorbid borderline personality disorder: demographic, clinical, and family history differences.
    Zimmerman M; Martinez JH; Morgan TA; Young D; Chelminski I; Dalrymple K
    J Clin Psychiatry; 2013 Sep; 74(9):880-6. PubMed ID: 24107761
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychopathologic differences between cannabis-induced psychoses and recent-onset primary psychoses with abuse of cannabis.
    Rubio G; Marín-Lozano J; Ferre F; Martínez-Gras I; Rodriguez-Jimenez R; Sanz J; Jimenez-Arriero MA; Carrasco JL; Lora D; Jurado R; López-Trabada JR; Palomo T
    Compr Psychiatry; 2012 Nov; 53(8):1063-70. PubMed ID: 22682680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring associations between borderline personality disorder, crack/cocaine dependence, gender, and risky sexual behavior among substance-dependent inpatients.
    Tull MT; Gratz KL; Weiss NH
    Personal Disord; 2011 Jul; 2(3):209-19. PubMed ID: 22448767
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Substance Use in Youth With Borderline Personality Disorder.
    Scalzo F; Hulbert CA; Betts JK; Cotton SM; Chanen AM
    J Pers Disord; 2018 Oct; 32(5):603-617. PubMed ID: 28926304
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of borderline personality disorder: do the number of criteria met make a difference?
    Asnaani A; Chelminski I; Young D; Zimmerman M
    J Pers Disord; 2007 Dec; 21(6):615-25. PubMed ID: 18072863
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comorbidity in patients with narcissistic personality disorder in comparison to patients with borderline personality disorder].
    Ritter K; Roepke S; Merkl A; Heuser I; Fydrich T; Lammers CH
    Psychother Psychosom Med Psychol; 2010 Jan; 60(1):14-24. PubMed ID: 19235677
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axis II comorbidity in borderline personality disorder is influenced by sex, age, and clinical severity.
    Barrachina J; Pascual JC; Ferrer M; Soler J; Rufat MJ; Andión O; Tiana T; Martín-Blanco A; Casas M; Pérez V
    Compr Psychiatry; 2011; 52(6):725-30. PubMed ID: 21349508
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A psychometric investigation of gender differences and common processes across borderline and antisocial personality disorders.
    Chun S; Harris A; Carrion M; Rojas E; Stark S; Lejuez C; Lechner WV; Bornovalova MA
    J Abnorm Psychol; 2017 Jan; 126(1):76-88. PubMed ID: 27808543
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comorbid attention-deficit/hyperactivity disorder in borderline patients defines an impulsive subtype of borderline personality disorder.
    Ferrer M; Andión O; Matalí J; Valero S; Navarro JA; Ramos-Quiroga JA; Torrubia R; Casas M
    J Pers Disord; 2010 Dec; 24(6):812-22. PubMed ID: 21158602
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of antisocial and borderline personality features in substance dependence among incarcerated females.
    Chapman AL; Cellucci T
    Addict Behav; 2007 Jun; 32(6):1131-45. PubMed ID: 16962249
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of sex to symptom severity, psychiatric comorbidity, and health care utilization in 163 subjects with borderline personality disorder.
    McCormick B; Blum N; Hansel R; Franklin JA; St John D; Pfohl B; Allen J; Black DW
    Compr Psychiatry; 2007; 48(5):406-12. PubMed ID: 17707247
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A study of psychotic symptoms in borderline personality disorder.
    Pearse LJ; Dibben C; Ziauddeen H; Denman C; McKenna PJ
    J Nerv Ment Dis; 2014 May; 202(5):368-71. PubMed ID: 24727723
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment area.
    Weibell MA; Joa I; Bramness J; Johannessen JO; McGorry PD; Ten Velden Hegelstad W; Larsen TK
    BMC Psychiatry; 2013 Nov; 13():319. PubMed ID: 24279887
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comorbidity study of borderline personality disorder: applying association rule mining to the Taiwan national health insurance research database.
    Shen CC; Hu LY; Hu YH
    BMC Med Inform Decis Mak; 2017 Jan; 17(1):8. PubMed ID: 28077135
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Borderline personality disorder and Axis I psychiatric and substance use disorders among women experiencing homelessness in three US cities.
    Whitbeck LB; Armenta BE; Welch-Lazoritz ML
    Soc Psychiatry Psychiatr Epidemiol; 2015 Aug; 50(8):1285-91. PubMed ID: 25708192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Borderline personality symptoms in short-term and long-term abstinent alcohol dependence.
    Fein G; Nip V
    Alcohol Clin Exp Res; 2012 Jul; 36(7):1188-95. PubMed ID: 22309234
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Borderline personality features and development of psychosis in an 'ultra high risk' (UHR) population: a case control study.
    Thompson A; Nelson B; Bechdolf A; Chanen AM; Domingues I; McDougall E; Yung AR
    Early Interv Psychiatry; 2012 Aug; 6(3):247-55. PubMed ID: 22672502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does co-occurring borderline personality disorder influence acute phase treatment for first-episode psychosis?
    Francey SM; Jovev M; Phassouliotis C; Cotton SM; Chanen AM
    Early Interv Psychiatry; 2018 Dec; 12(6):1166-1172. PubMed ID: 28516734
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.